STOCK TITAN

Akamai (AKAM) CTO Robert Blumofe sells 243 shares in pre-set 10b5-1 trade

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Akamai Technologies Chief Technology Officer Robert Blumofe reported a small open-market sale of company stock. He sold 243 shares of common stock at a price of $129.41 per share in a coded "S" transaction. After this sale, he directly holds 31,006 shares and also has 152.944 shares held indirectly through a 401(k) plan. The filing notes that the sale was carried out under a pre-arranged Rule 10b5-1 trading plan adopted by Blumofe, indicating it was scheduled in advance rather than timed discretionarily.

Positive

  • None.

Negative

  • None.
Insider Blumofe Robert
Role Chief Technology Officer
Sold 243 shs ($31K)
Type Security Shares Price Value
Sale Common Stock 243 $129.41 $31K
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 31,006 shares (Direct, null); Common Stock — 152.944 shares (Indirect, By 401(k) Plan)
Footnotes (1)
  1. Sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. As of June 17, 2026.
Shares sold 243 shares Open-market sale of Akamai common stock
Sale price per share $129.41 per share Price for the 243 shares sold
Direct holdings after sale 31,006 shares Common stock directly owned following the transaction
Indirect 401(k) holdings 152.944 shares Common stock held indirectly via 401(k) plan
Rule 10b5-1 trading plan regulatory
"Sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
401(k) Plan financial
"nature_of_ownership": "By 401(k) Plan""
A 401(k) plan is a workplace retirement account that lets employees set aside part of their pay into a tax-advantaged savings pot, often with employers adding matching contributions — like a workplace piggy bank for future income. It matters to investors because the amount people save and how employers fund these plans influence consumer spending, corporate payroll costs and the flow of money into financial markets, which can affect stock prices and company valuations.
Common Stock financial
"security_title": "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Blumofe Robert

(Last)(First)(Middle)
C/O AKAMAI TECHNOLOGIES, INC.
145 BROADWAY

(Street)
CAMBRIDGE MASSACHUSETTS 02142

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
AKAMAI TECHNOLOGIES INC [ AKAM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Technology Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/18/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/18/2026S(1)243D$129.4131,006D
Common Stock152.944(2)IBy 401(k) Plan
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.
2. As of June 17, 2026.
Remarks:
/s/ Thomas M. Lair, as power of attorney06/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did AKAM Chief Technology Officer Robert Blumofe report?

Robert Blumofe reported an open-market sale of 243 shares of Akamai common stock. The shares were sold at $129.41 per share, and the transaction is coded "S" as a sale in the Form 4 filing.

How many AKAM shares does Robert Blumofe hold after this Form 4 transaction?

After the reported sale, Robert Blumofe directly holds 31,006 Akamai common shares. He also has an additional 152.944 shares held indirectly through a 401(k) plan, according to the Form 4 ownership details.

Was Robert Blumofe’s AKAM stock sale made under a Rule 10b5-1 plan?

Yes. A footnote states the sale was made pursuant to a Rule 10b5-1 trading plan adopted by Robert Blumofe. Such plans pre-schedule trades, reducing the significance of trade timing as a signal of insider sentiment.

What price did Robert Blumofe receive per AKAM share in the reported sale?

The Form 4 shows a sale price of $129.41 per Akamai common share. This price applies to the 243 shares sold in the reported open-market transaction coded as an "S" sale.

How many AKAM shares did Robert Blumofe sell in this Form 4 filing?

Robert Blumofe sold 243 shares of Akamai common stock in this transaction. The filing categorizes it as a non-derivative, open-market sale, reducing his direct holdings but leaving a substantial remaining position.

Does Robert Blumofe have indirect AKAM holdings after the reported transaction?

Yes. In addition to his direct 31,006 Akamai shares, the Form 4 reports 152.944 shares held indirectly. These indirect shares are held via a 401(k) plan, as indicated by the ownership description.